Monopar Therapeutics (MNPR) has 18 open-market insider trades by 12 insiders since 2019. The most active filer is Andrew Cittadine, COO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Tactic Pharma LLC | CEOCSODir10% Owner | — | 2 | $36.8M | 2025-09-24 |
| Diane Hendricks | 10% Owner | — | 1 | $3.8M | 2025-12-16 |
| Karl Leo | 10% Owner | — | 1 | $1.3M | 2019-12-18 |
| Michael J. Brown | CEO | — | 1 | $1.2M | 2025-04-02 |
| Thomas V. O'Halloran | CEOCSODir10% Owner | — | 1 | $1.0M | 2019-12-18 |
| Chandler Robinson | CEO | — | 1 | $672K | 2026-09-30 |
| Christopher M. Starr | Dir | — | 1 | $672K | 2025-07-14 |
| Kim R. Tsuchimoto | Dir | — | 2 | $359K | 2026-08-26 |
| Arthur J. Klausner | Dir | — | 1 | $344K | 2025-12-18 |
| Andrew Cittadine | COO | — | 5 | $150K | 2026-09-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Christopher M. Starr | Director | Sell | $659K | 2026-10-01 |
| Chandler Robinson | CEO | Sell | $2.6M | 2026-09-24 |
| Kim R. Tsuchimoto | Director | Sell | $456K | 2026-08-26 |
| Patrice Rioux | — | Sell | $111 | 2026-08-26 |
| Raymond Anderson | Director | Sell | $72K | 2026-08-25 |
| Raymond Anderson | Director | Sell | $351K | 2026-08-25 |
Companies that share insiders with MNPR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Quan Anh Vu | CFO | Buy | $105K | 2025-12-26 |
| Arthur J. Klausner | Director | Sell | $344K | 2025-12-18 |
| Tactic Pharma LLC | CEO & 10% | Sell | $35.0M | 2025-09-24 |
| Chandler Robinson | CEO | Sell | $672K | 2025-07-14 |
| Kim R. Tsuchimoto | Director | Sell | $356K | 2025-07-14 |
| Michael J. Brown | CEO | Sell | $1.2M | 2025-04-02 |
| Karthik Radhakrishnan | CFO | Buy | $25K | 2024-10-28 |
| Andrew Cittadine | COO | Buy | $25K | 2024-06-18 |
| Andrew Cittadine | COO | Buy | $33K | 2024-06-13 |